Correlation Between Franklin Genomic and Motley Fool

Can any of the company-specific risk be diversified away by investing in both Franklin Genomic and Motley Fool at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Franklin Genomic and Motley Fool into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Franklin Genomic Advancements and Motley Fool Global, you can compare the effects of market volatilities on Franklin Genomic and Motley Fool and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Franklin Genomic with a short position of Motley Fool. Check out your portfolio center. Please also check ongoing floating volatility patterns of Franklin Genomic and Motley Fool.

Diversification Opportunities for Franklin Genomic and Motley Fool

-0.51

Correlation Coefficient

Franklin Genomic  Motley Fool

Excellent diversification

The 3 months correlation between Franklin and Motley is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Franklin Genomic Advancements and Motley Fool Global in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Motley Fool Global and Franklin Genomic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Franklin Genomic Advancements are associated (or correlated) with Motley Fool. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Motley Fool Global has no effect on the direction of Franklin Genomic i.e., Franklin Genomic and Motley Fool go up and down completely randomly.

Pair Corralation between Franklin Genomic and Motley Fool

Given the investment horizon of 90 days Franklin Genomic Advancements is expected to under-perform the Motley Fool. In addition to that, Franklin Genomic is 1.99 times more volatile than Motley Fool Global. It trades about -0.07 of its total potential returns per unit of risk. Motley Fool Global is currently generating about 0.2 per unit of volatility. If you would invest  3,135  in Motley Fool Global on September 12, 2024 and sell it today you would earn a total of  250.80  from holding Motley Fool Global or generate 8.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Franklin Genomic Advancements  vs.  Motley Fool Global

Franklin Genomic Adv

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Franklin Genomic Advancements has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong essential indicators, Franklin Genomic is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Motley Fool Global

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Motley Fool Global are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating technical and fundamental indicators, Motley Fool may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Franklin Genomic and Motley Fool

The main advantage of trading using opposite Franklin Genomic and Motley Fool positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Franklin Genomic position performs unexpectedly, Motley Fool can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Motley Fool will offset losses from the drop in Motley Fool's long position.

The idea behind Franklin Genomic Advancements and Motley Fool Global pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..